OrthoPediatrics Corp. (NASDAQ:KIDS) Short Interest Down 12.3% in November

OrthoPediatrics Corp. (NASDAQ:KIDS) was the recipient of a large decline in short interest during the month of November. As of November 15th, there was short interest totalling 801,100 shares, a decline of 12.3% from the October 31st total of 913,900 shares. Based on an average trading volume of 162,600 shares, the days-to-cover ratio is presently 4.9 days. Currently, 4.9% of the company’s shares are short sold.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Quarry LP acquired a new position in OrthoPediatrics during the third quarter worth $25,000. International Assets Investment Management LLC raised its holdings in shares of OrthoPediatrics by 2,610.8% in the third quarter. International Assets Investment Management LLC now owns 1,003 shares of the company’s stock valued at $27,000 after purchasing an additional 966 shares during the last quarter. Quest Partners LLC purchased a new stake in shares of OrthoPediatrics in the second quarter valued at about $34,000. BNP Paribas Financial Markets raised its holdings in shares of OrthoPediatrics by 125.1% in the third quarter. BNP Paribas Financial Markets now owns 3,471 shares of the company’s stock valued at $94,000 after purchasing an additional 1,929 shares during the last quarter. Finally, SG Americas Securities LLC purchased a new stake in shares of OrthoPediatrics in the second quarter valued at about $110,000. Institutional investors and hedge funds own 69.05% of the company’s stock.

OrthoPediatrics Stock Down 1.0 %

Shares of OrthoPediatrics stock traded down $0.27 during trading on Monday, reaching $25.71. 28,650 shares of the company traded hands, compared to its average volume of 167,776. The company has a debt-to-equity ratio of 0.19, a current ratio of 7.17 and a quick ratio of 3.68. The company has a 50 day moving average price of $26.04 and a 200-day moving average price of $29.08. OrthoPediatrics has a 1-year low of $22.41 and a 1-year high of $36.23. The firm has a market capitalization of $622.70 million, a PE ratio of -21.12 and a beta of 1.16.

Wall Street Analyst Weigh In

A number of research firms have weighed in on KIDS. Needham & Company LLC reissued a “buy” rating and set a $42.00 target price on shares of OrthoPediatrics in a report on Friday, November 8th. Truist Financial reduced their price objective on shares of OrthoPediatrics from $34.00 to $28.00 and set a “hold” rating on the stock in a research note on Monday, October 14th. Finally, JMP Securities reiterated a “market outperform” rating and set a $50.00 target price on shares of OrthoPediatrics in a research report on Friday, September 13th.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.